Acessibilidade / Reportar erro

Characteristics and thermodynamics of the interaction of 6-shogaol with human serum albumin as studied by isothermal titration calorimetry

ABSTRACT

The interaction between 6-shogaol, a pharmacologically active ginger constituent, and human serum albumin (HSA), the main in vivo drug transporter, was investigated using isothermal titration calorimetry (ITC). The value of the binding constant, Ka (5.02 ± 1.37 × 104 M−1) obtained for the 6-shogaol-HSA system suggested intermediate affinity. Analysis of the ITC data revealed feasibility of the binding reaction due to favorable enthalpy and entropy changes. The values of the thermodynamic parameters suggested involvement of van der Waals forces, hydrogen bonds and hydrophobic interactions in the 6-shogaol-HSA complex formation.

Uniterms:
6-Shogaol; Human serum albumin/Isothermal titration calorimetry; Ligand-protein interaction.

INTRODUCTION

Natural products and their bioactive constituents are increasingly recognized as sources for the discovery of new drugs and the treatment of diseases. The rhizome of Zingiber officinale (common ginger) is a particularly rich source of bioactive phytochemicals of different classes; it is thus a major target for discovering new phytomedicines (Bode, Dong, 2011). One of the pharmacologically significant compounds that is abundantly present in this rhizome is 6-shogaol, whose structure is shown in Figure 1. Its therapeutic properties have been extensively studied and it is well established that 6-shogaol possesses significant anticancer, antioxidant and anti-inflammatory potential (Chen et al., 2012CHEN, H.; LV, L.; SOROKA, D.; WARIN, R.F.; PARKS, T.A.; HU, Y.; ZHU, Y.; CHEN, X.; SANG, S. Metabolism of [6]-shogaol in mice and in cancer cells. Drug Metab. Dispos., v.40, n.4, p.742-753, 2012.; Chrubasik, Pittler, Roufogalis, 2005CHRUBASIK, S.; PITTLER, M.H.; ROUFOGALIS, B.D. Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, v.12, n.9, p.684-701, 2005.; Ha et al., 2012HA, S.K.; MOON, E.; JU, M.S.; KIM, D.H.; RYU, J.H.; OH, M.S.; KIM, S.Y. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology, v.63, n.2, p.211-223, 2012.).

FIGURE 1
Chemical structure of 6-shogaol.

The efficacy of biologically active compounds as pharmaceutical agents depends mainly upon their interactions with proteins in the circulatory system. Human serum albumin (HSA) is the most abundant serum protein in the body and serves as the major carrier protein for a wide variety of molecules, including drugs and metabolites (Peters, 1996PETERS, T.Jr. All about albumin: Biochemistry, genetics and medical applications. San Diego: Academic Press, 1996. 432 p.). Therefore, it plays a dominant role in drug disposition, affecting the biodistribution, metabolism and elimination of the molecules to which it binds (Peters, 1996). Hence, characterization of ligand-protein interactions is vital in order to determine the pharmacokinetic profiles of these compounds and to assess their therapeutic potential.

Isothermal titration calorimetry (ITC) has emerged as a widely used biophysical tool to monitor binding reactions and to evaluate the thermodynamic parameters involved in such processes (Bou-Abdallah, Terpstra, 2012). This technique directly measures the heat changes associated with a reaction and allows for a complete characterization of the energetics of a system (Leavitt, Freire, 2001LEAVITT, E.; FREIRE, E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struc. Biol., v.11, n.5, p.560-566, 2001.). Although other methods are also able to provide information about the binding affinity of ligand-protein interactions, only ITC is capable of measuring in a single experiment the thermodynamic terms that define the binding affinity (Leavitt, Freire, 2001).

In view of the advantages offered by ITC for studying binding reactions involving biomolecules, we present the binding properties of 6-shogaol to HSA, including quantification of the thermodynamics governing this interaction, as obtained from ITC data.

MATERIALS AND METHODS

Materials

Defatted human serum albumin (HSA) (Lot #068K7538V) was acquired from Sigma-Aldrich Co. (St. Louis, MO, USA), and 6-shogaol was isolated from the rhizomes of Zingiber officinale var. officinale, following standard procedures (Jolad et al., 2004JOLAD, S.D.; LANTZ, R.C.; SOLYOM, A.M.; CHEN, G.J.; BATES, R.B.; TIMMERMAN, B.N. Fresh organically grown ginger (Zingiber officinale): Composition and effects on LPS-induced PGE2 production. Phytochemistry., v.65, n.13, p.1937-1954, 2004., 2005; Kim et al., 2008KIM, J.S.; LEE, S.I.; PARK, H.W.; YANG, J.H.; SHIN, T.Y.; KIM, Y.C.; BAEK, N.I.; KIM, S.H.; CHOI, S.U.; KWON, B.M.; LEEM, K.H.; JUNG, M.Y.; KIM, D.K. Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch. Pharm. Res., v.31, n.4, p.415-418, 2008. ). The purity of the compound was >95% based on nuclear magnetic resonance (NMR) analysis. All other chemicals used were of analytical grade purity.

Analytical procedures

HSA stock solution (30 µM) was prepared in 10 mM sodium phosphate buffer, pH 7.4, and its concentration was determined spectrophotometrically using E 1% 1cm of 5.3 at 280 nm (Wallevik, 1973WALLEVIK, K. Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. Biol. Chem., v.248, n.8, p.2650-2655, 1973.). Absorbance measurements were made on a Shimadzu UV-2450 double beam spectrophotometer (Shimadzu Corp., Kyoto, Japan) using quartz cuvettes with a 1 cm path length. The stock solution of 6-shogaol (10 mg mL-1) was prepared by dissolution in absolute ethanol.

Isothermal titration calorimetry

ITC experiments were performed on a Nano ITC microcalorimeter (TA Instruments, New Castle, DE, USA) at 25 °C. The titrant (6-shogaol) and protein solutions were prepared in the same buffer (10 mM sodium phosphate buffer, pH 7.4) and degassed under vacuum for 20 min prior to the titration experiments. After loading the sample and reference cells with HSA (25 μM) and buffer alone, respectively, a syringe (250 μL) containing 6-shogaol (380 μM) was placed into the microcalorimeter. The titration experiment involved 25 consecutive injections of 10 μL of titrant added intermittently every 400 s, with a stirring speed of 250 rpm to ensure homogeneous mixing of the solutions. Appropriate blank experiments involving injections of the ligand into the buffer solution were also performed under similar conditions for correcting the heat of the dilution and the mixing of the solutions. Both the HSA and the buffer solutions contained the same concentration of ethanol (2.5%) as in the 6-shogaol solution, in order to nullify the effect of heat generation due to solvent dilution.

The amount of heat, Q, liberated with each injection was calculated by integrating the heat-rate peaks using NanoAnalyze 2.4.1 software (TA Instruments, New Castle, DE, USA). The corrected calorimetric data were analyzed based on an independent binding model to determine the values of the association constant (Ka ) and binding stoichiometry (n), as well as the enthalpy and entropy changes (ΔH and ΔS) of the reaction. The value of the free-energy change (ΔG) was subsequently calculated with the help of the following equation:

Δ G = Δ H - T Δ S(1)

The experiments were performed in four replicates, and the results are presented as the average ± standard deviation of the three best replicates.

RESULTS AND DISCUSSION

ITC experiments were carried out to determine the binding characteristics and the thermodynamics of the interaction between 6-shogaol and HSA. Figure 2A shows the ITC thermogram at 25 °C, depicting the calorimetric response upon the binding of 6-shogaol to HSA. As can be seen in the figure, the negative peaks resulting from the reaction suggested the exothermic nature of the binding process. Integration of the heat rates into the total heat released (Q) per mol of titrant was plotted against the ligand/protein molar ratio, shown in Figure 2B. Analysis of the binding isotherm using an independent binding model yielded the values of the binding and thermodynamic parameters (Table I).

FIGURE 2
(A) Calorimetric response to successive injections of 6-shogaol (380 µM) into HSA (25 µM). (B) Integrated plot of the amount of heat liberated (Q) per injection as a function of the 6-shogaol/HSA molar ratio.

TABLE I
Binding and thermodynamic parameters of the interaction between 6-shogaol and HSA derived from ITC measurements at pH 7.4 and 25 °C

The Ka value obtained for the 6-shogaol-HSA system (5.02 × 104 M−1) was found to be in the range of 1-15 × 104 M−1, which is shown for a number of other ligand-protein complexes (Dufour, Dangles, 2005DUFOUR, C.; DANGLES, O. Flavonoid-serum albumin complexation: Determination of binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta, v.1721, n.1-3, p.164-173, 2005.), indicating intermediate affinity between 6-shogaol and HSA. This value of Ka is desirable for the transportation of the ligand in circulation, as well as its release at the target site. On the other hand, the binding stoichiometry of the reaction, n, was found to be 1.31. The positive sign for the ΔS value and the negative sign for the ΔH value showed that the binding process was both entropically and enthalpically favorable at 25 °C and contributed significantly to the thermodynamic feasibility of the reaction, as evident from the negative sign for the ΔG value (Table I).

The values of these thermodynamic parameters can shed light on the intermolecular forces involved in the interaction between 6-shogaol and HSA. The observed entropic gain may be ascribed to the disruption of water layers originally surrounding the ligand and protein molecules, due to the involvement of hydrophobic interactions in the complex formation (Ross, Subramanian, 1981ROSS, P.D.; SUBRAMANIAN, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, v.20, p.3096-3102, 1981.). Since the formation of hydrogen bonds and van der Waals forces frequently result in heat evolution (Ross, Subramanian, 1981), a negative value for ΔH also points to the involvement of these forces in the 6-shogaol-HSA interaction. It is interesting to note that the binding reaction is enthalpy-dominated under the experimental conditions used, suggesting that hydrogen bonding in particular is the major force involved in the complexation between 6-shogaol and HSA. The participation of these intermolecular forces in the binding of 6-shogaol to HSA is well-supported by the structural features of 6-shogaol, which possesses both apolar and polar characteristics (Figure 1). As suggested in earlier reports (Caruso et al., 2014CARUSO, I.P.; VILEGAS, W.; DE SOUZA, F.P.; FOSSEY, M.A.; CORNELIO, M.L. Binding of antioxidant flavone isovitexin to human serum albumin investigated by experimental and computational assays. J. Pharm. Biomed., v.98, p.100-106, 2014.; Feroz et al., 2012FEROZ, S.R.; MOHAMAD, S.B.; BUJANG, N.; MALEK, S.N.A.; TAYYAB, S. Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin. J. Agr. Food Chem., v.60, n.23, p.5899-5908, 2012., 2013; Molina-Bolivar et al., 2014; Neamtu, Tosa, Bogdan, 2013NEAMTU, S.; TOSA, N.; BOGDAN, M. Spectroscopic investigation of tolmetin interaction with human serum albumin. J. Pharm. Biomed., v.85, p.277-282, 2013.), it is not possible to account for the observed thermodynamic parameters according to a single intermolecular-force model. Therefore, the energetics data obtained in this study seem to reflect the collective contributions of hydrophobic interactions, van der Waals forces and hydrogen bonds in 6-shogaol-HSA complexation.

CONCLUSION

In summary, the present study elucidates the binding properties and thermodynamic quantities of the interaction between 6-shogaol and HSA. The calorimetric data suggested that the binding is of intermediate affinity and is mediated by van der Waals forces, hydrogen bonds and hydrophobic interactions. These results can be helpful in understanding chemico-biological interactions in drug design.

ACKNOWLEDGEMENTS

This work was financially supported by the University of Malaya via the Postgraduate Research Fund (PG073/2013B) to S.R.F. We thank the dean of the Faculty of Science and the head of the Institute of Biological Sciences at the University of Malaya for providing the necessary facilities.

REFERENCES

  • BODE, A.M.; DONG, Z. The amazing and mighty ginger. In: BENZIE, I.F.F.; WACHTEL-GALOR, S. (Ed.). Herbal medicine: Biomolecular and clinical aspects. Boca Raton: CRC Press, 2011. p.131-156.
  • BOU-ABDALLAH, F.; TERPSTRA, T.R. The thermodynamic and binding properties of the transferrins as studied by isothermal titration calorimetry. Biochim. Biophys. Acta, v.1820, n.3, p.318-325, 2012.
  • CARUSO, I.P.; VILEGAS, W.; DE SOUZA, F.P.; FOSSEY, M.A.; CORNELIO, M.L. Binding of antioxidant flavone isovitexin to human serum albumin investigated by experimental and computational assays. J. Pharm. Biomed., v.98, p.100-106, 2014.
  • CHEN, H.; LV, L.; SOROKA, D.; WARIN, R.F.; PARKS, T.A.; HU, Y.; ZHU, Y.; CHEN, X.; SANG, S. Metabolism of [6]-shogaol in mice and in cancer cells. Drug Metab. Dispos., v.40, n.4, p.742-753, 2012.
  • CHRUBASIK, S.; PITTLER, M.H.; ROUFOGALIS, B.D. Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, v.12, n.9, p.684-701, 2005.
  • DUFOUR, C.; DANGLES, O. Flavonoid-serum albumin complexation: Determination of binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta, v.1721, n.1-3, p.164-173, 2005.
  • FEROZ, S.R.; MOHAMAD, S.B.; BUJANG, N.; MALEK, S.N.A.; TAYYAB, S. Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin. J. Agr. Food Chem., v.60, n.23, p.5899-5908, 2012.
  • FEROZ, S.R.; MOHAMAD, S.B.; BAKRI, Z.S.D.; MALEK, S.N.A.; TAYYAB, S. Probing the interaction of a therapeutic flavonoid, pinostrobin with human serum albumin: Multiple spectroscopic and molecular modeling investigations. PLoS ONE, v.8, n.10, e76067, 2013.
  • HA, S.K.; MOON, E.; JU, M.S.; KIM, D.H.; RYU, J.H.; OH, M.S.; KIM, S.Y. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology, v.63, n.2, p.211-223, 2012.
  • JOLAD, S.D.; LANTZ, R.C.; SOLYOM, A.M.; CHEN, G.J.; BATES, R.B.; TIMMERMAN, B.N. Fresh organically grown ginger (Zingiber officinale): Composition and effects on LPS-induced PGE2 production. Phytochemistry., v.65, n.13, p.1937-1954, 2004.
  • JOLAD, S.D.; LANTZ, R.C.; CHEN, G.J.; BATES, R.B.; TIMMERMAN, B.N. Commercially processed dry ginger (Zingiber officinale): Composition and effects on LPS-stimulated PGE2 production. Phytochemistry, v.66, n.13, p.1614-1635, 2005.
  • KIM, J.S.; LEE, S.I.; PARK, H.W.; YANG, J.H.; SHIN, T.Y.; KIM, Y.C.; BAEK, N.I.; KIM, S.H.; CHOI, S.U.; KWON, B.M.; LEEM, K.H.; JUNG, M.Y.; KIM, D.K. Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe. Arch. Pharm. Res., v.31, n.4, p.415-418, 2008.
  • LEAVITT, E.; FREIRE, E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struc. Biol., v.11, n.5, p.560-566, 2001.
  • MOLINA-BOLIVAR, J.A.; GALISTEO-GONZALEZ, F.; CARNERO RUIZ, C.; MEDINA-O' DONNELL, M.; PARRA, A. Spectroscopic investigation on the interaction of maslinic acid with bovine serum albumin. J. Lumin., v.156, p.141-149, 2014.
  • NEAMTU, S.; TOSA, N.; BOGDAN, M. Spectroscopic investigation of tolmetin interaction with human serum albumin. J. Pharm. Biomed., v.85, p.277-282, 2013.
  • PETERS, T.Jr. All about albumin: Biochemistry, genetics and medical applications. San Diego: Academic Press, 1996. 432 p.
  • ROSS, P.D.; SUBRAMANIAN, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry, v.20, p.3096-3102, 1981.
  • WALLEVIK, K. Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. Biol. Chem., v.248, n.8, p.2650-2655, 1973.

Publication Dates

  • Publication in this collection
    Sept 2016

History

  • Received
    27 July 2015
  • Accepted
    03 June 2016
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas Av. Prof. Lineu Prestes, n. 580, 05508-000 S. Paulo/SP Brasil, Tel.: (55 11) 3091-3824 - São Paulo - SP - Brazil
E-mail: bjps@usp.br